Cingulate Inc. (CING) Debt Components
- 2026-06-30: Notes Payable, CurrentUSD $5.07M; Debt Instrument, Face AmountUSD (m); Notes PayableUSD (m); Debt Instrument, Interest Rate, Effective Percentagepure (m).
- 2026-03-31: Notes Payable, CurrentUSD $6.15M; Debt Instrument, Face AmountUSD (m); Notes PayableUSD (m); Debt Instrument, Interest Rate, Effective Percentagepure (m).
- 2025-12-31: Notes Payable, CurrentUSD $6.30M; Debt Instrument, Face AmountUSD (m); Notes PayableUSD (m); Debt Instrument, Interest Rate, Effective Percentagepure (m).
- 2025-09-30: Notes Payable, CurrentUSD $3.18M; Debt Instrument, Face AmountUSD (m); Notes PayableUSD (m); Debt Instrument, Interest Rate, Effective Percentagepure (m).
Cingulate Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable, Current USD | Debt Instrument, Face Amount USD | Notes Payable USD | Debt Instrument, Interest Rate, Effective Percentage pure |
|---|---|---|---|---|
| 2026-06-30 | $5.07M | (m) | (m) | (m) |
| 2026-03-31 | $6.15M | (m) | (m) | (m) |
| 2025-12-31 | $6.30M | (m) | (m) | (m) |
| 2025-09-30 | $3.18M | (m) | (m) | (m) |
| 2025-06-30 | $5.13M | (m) | (m) | (m) |
| 2025-03-31 | $4.12M | (m) | (m) | (m) |
| 2024-12-31 | $2.53M | (m) | (m) | (m) |
| 2023-12-31 | $3.00M | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | $2.10M | (m) |
| 2023-09-30 | $3.00M | $3.00M | $2.10M | (m) |
| 2023-06-30 | $8.00M | $8.00M | (m) | (m) |
| 2023-05-31 | (m) | $8.00M | (m) | (m) |
| 2023-05-09 | (m) | $8.00M | (m) | (m) |
| 2023-05-09 | (m) | (m) | $3.00M | (m) |
| 2023-03-31 | $5.00M | (m) | (m) | (m) |
| 2022-12-31 | $5.00M | (m) | (m) | (m) |
| 2022-12-31 | (m) | $5.00M | (m) | (m) |
| 2022-09-30 | $5.00M | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | 25.00% |
| 2020-12-31 | $500.33K | (m) | $500.33K | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |